25 PEOPLE POWER: THE KEYTO TRANSFORMING HEALTHCARE CAPABILITY CENTERS IN INDIA
26 THE CONCEPTOF MEDICALLEXPO WAS BORN OUTOF APRESSING NEED IN THE INDIAN HEALTHCARE SECTOR EVENTS
Regd.With RNI No.MAHENG/2007/22045.Postal Regd.No.MCS/162/2025 - 27.Printed and Published byVaidehi Thakar on behalf of The Indian Express (P) Limited and Printed at The Indian Express Press,Plot No.EL-208,TTC Industrial Area,Mahape,Navi Mumbai-400710 and Published at Mafatlal Centre,7th floor,Ramnath Goenka Marg,Nariman Point,Mumbai 400021.
President Trump’s Liberation Day tariffs have plunged India’s medical device sector into a funk, as it grapples with the impact ofthe 26 per cent reciprocal tariffs on US exports. A twin worry is non-tariff barriers (NTBs), like regulatory hurdles related to registration and inspection charges etc. Over the last decade, India has also expanded its own version of NBTs like Quality Control Orders (QCOs) for reasons ranging from consumer safety, public health, and national security.
The tariff axe could fall again in the future so it's best that med device companies take proactive action. This includes diversifying their export base, and moving up the value chain from low-value high volume consumables to high-value medical devices. This is similar to the growth strategy of India’s pharmaceutical sector, which moved from plain vanilla generics to speciality, difficult to make generics and biologics, where the entry barriers curtail competitio and keep margins healthier. The med devices sector needs to simultaneously work on policymakers to reduce NTBs.
Proactively upping our game to a more value-added positioning is a must, given that there are already signs that President Trump is not yet done. After exempting pharma exports in the first round, media reports have quoted President Trump saying that this is “under review right now”, “pharma tariffs are going to come in at levels you haven't really seen before….”
The tit-for-tat tariff regime will spur more unethical practices and unleash a race to the bottom. For instance, Rajiv Nath, Forum Coordinator, Association of Indian Medical Device Industry (AiMeD), reveals that the biggest fear for India’s medical device exporters is the routing of exports to countries with lower tariffs (like the UK and UAE which have 10 per cent tariffs). This is reportedly a common tactic of India’s competitor China.
The US has levied heavier tariffs on medical devices imported from other countries (China: 34 per cent, Vietnam: 46 per cent, Switzerland: 31 per cent). But this difference is not necessarily in India’s favour. As Himanshu Baid, managing director, Poly Medicure comments, while India may seemingly gain a marginal price advantage over China (8 per cent) in certain low-risk, high-volume consumables, the real impact may not be significant if our prices were higher than 15 per cent and the impact has to be further studied compared to other competing nations.
Besides the tariff challenges, NTBs are considerable. Nath points out that while regulatory hurdles in the US are steep, with FDA approval costs ranging from $9,280 to over $540,000, US exporters face relatively minimal costs when entering India. Therefore addressing these imbalances through bilateral collaboration is crucial, states Nath. He harks back to Prime Minister Modi’s diktat that India must prioritise healthcare security by strengthening domestic manufacturing and reducing dependency on foreign markets.
Global medtech companies operating in India have also protested against the tariffs. Pavan Choudary, Chairman, Medical Technology Association of India (MTaI), which represents global players, believes that the US administration's decision to impose reciprocal tariffs “does not reflect informed policymaking”, reasoning that history has repeatedly shown that “protectionist measures often do more harm than good, with the burden ultimately falling on consumers and patients in both countries.”
Making India the med device makers/innovator of the world needs an image shift from low cost to high value.Does the nation,and individual med devices companies,have the financial resources to invest in innovation,faced with dwindling exports,as it plays catch up to other contenders to this crown?
In fact, tariffs on medical device imports could achieve exactly the opposite effect of their initial intent. As Choudary points out, “Economies prosper when they focus on their strengths, leveraging comparative advantages to enhance global trade. However, by disrupting supply chains through excessive tariffs, the US risks not only reducing efficiency but also increasing healthcare costs for its own citizens. The decisions of reciprocal tariff on Indian imports stem from trade imbalances and perceived non-tariff barriers in sectors like medical devices and is intended to protect domestic industries but could inadvertently stifle the spirit of free and fair trade that benefits both nations. Instead of escalating trade restrictions, both countries should move to a more strategic, non protectionist and cooperative approach that would serve long-term economic interests.”
Policy makers have always used trade as a tool. For instance, India has used QCOs to control cross border trade. As Ranjeet Mahtani, Partner, Dhruva Advisors points out, there has been a sharp rise in QCOs in the past decade. In 2014 there were only 14 QCOs covering 106 products, compared to approximately 187 QCOs covering 769 products notified for compulsory BIS certification by early 2025.
Among other examples, Mahtani cites The Medical and Surgical Gloves (Quality Control) Order, 2024 which was notified (through the Department of Chemicals & Petrochemicals and Department of Pharmaceuticals) to clamp down on low-quality surgical gloves in the Indian market. The driver for this move was the discovery of substandard glove imports flooding in from Malaysia, Thailand, Vietnam, and China.
There is no doubt that the threat of US reciprocal tariffs has already galvanised India’s policy makers. TheGovernment of India had announced the Export Promotion Council for Medical Devices (EPCMD) in April 2023. But the council became functional by onboarding members just a few days before the US tariffs were announced. The council has its work cut out: it will have to quickly deal with higher reciprocal tariffs from the US, which will drastically reduce export revenues from the biggest market.
Therefore the focus will have to be on exploring new export destinations for Made in India medical devices as well as working at the policy level to scale back the tariffs. Both AiMed andMTaI haverequested Government of India’s support in bilateral negotiations for a more balanced approach to tariffs and regulatory policies.
Moving from low risk-high volume medical devices/ consumables to high risk-low volume medical devices is therefore of critical importance. Making India the med device maker/ innovator of the world needs an image shift from low cost to high value. Does the nation, and individual med devices companies, have the financial resources to invest in innovation, faced with dwindling exports, as it plays catch up to other contenders to this crown? Could India focus on niches like frugal medtech innovation? And is there any other choice?
Basic glaucoma investigations should be made available in all eye care facilities
Dr Neelima Shah, Consultant Ophthalmologist,Dr Agarwal's Eye Hospital,Bengaluru, discusses about glaucoma care in India,its diagnosis,and advancements in technology in an interaction with Kalyani Sharma
What are the biggest challenges in early detection and diagnosis of glaucoma in India?
The biggest challenges in early diagnosis of glaucoma in India are lack of awareness about the disease as well as the need for regular check ups, lack of access to eye care facilities and the prevalence of myths and misinformation about the disease.
What advancements have been made in glaucoma diagnostics? How do you see the role of technology improving detection rates?
The diagnostic equipments and methods for optic nerve scanning, visual field testing and intraocular pressure measurement have many advancements to take care of the space, access and budget constraints. They are available in portable and handheld forms now so that they can be kept in smaller eye care centres and also be transported across regions and to the remote areas with less eye care facilities. Telemedicine helps with interpretation of investigations and consultation with the specialists. The refinement in technology has made it possible to detect glaucoma in very early stages before it causes irreversible damage to functional vision.
With the rise of minimally invasive glaucoma surgeries (MIGS), how are treatment paradigms shifting, and where does India stand in terms of adoption?
With the invention and adoption of minimally invasive glaucoma surgeries (MIGS), surgical results have
significantly improved as these
The diagnostic equipments and methods for optic nerve scanning,visual field testing and intraocular pressure measurement have many advancements to take care of the space,access and budget constraints
How can hospitals and eye care centers integrate glaucoma care into their broader ophthalmology services to ensure continuity of care?
Hospitals and eye care centers should promote and conduct annual eye screening including glaucoma evaluation for people above 40 years of age. Special attention should be given to patients having risk factors associated with glaucoma such as family history, steroid usage, diabetes, high refractive error etc. Vision check, intraocular pressure measurement and clinical examination of optic nerve and retina should be integral parts of regular eye check up. Basic glaucoma investigations should be made available in all eye care facilities. Paramedical staff should be trained in helping doctors in doing glaucoma related screening and investigations.
What role do industry collaborations and publicprivate partnerships play in strengthening glaucoma and eye care services in India?
Organising eye care and glaucoma screening camps and activities, facilitating the awareness programs, making the test equipment and facilities available through industrial funds and training medical and paramedical staff in detecting glaucoma can be best achieved and strengthened through industry collaboration and public-private partnerships.
Express Healthcare successfully organised the GenNext Hospital Summit 2025 in Chennai on March 12. This event series is designed to foster the development of next-generation hospitals equipped to navigate the evolving healthcare landscape and meet dynamic patient needs.
The theme for this year, "Building a Future-Ready Healthcare Ecosystem," brought together industry leaders, experts, and decisionmakers to explore emerging trends, challenges, and opportunities shaping the future of healthcare. The event was supported by Silver Partners-
L-R:Prof Dr Navin Gnanasekaran,Head-clinical services radiology& interventional radiology,Apollo Group of Hospitals; Dr S.KarthickPrabhu,Secretary,IMATamil Nadu: Dr Sai Surendar Mohan,Group Head-Emergency Medicine,Kamakshi Memorial Hospital (Moderator); Dr N Kannan,Group medical director,Mehta Multispeciality Hospital: Dr Natesh B,COO,Lifeline MultispecialityHospitals: R.A.Nadesan,Director,SRM Group
Keynote address
At the GenNext Hospital Summit 2025 (Chennai edition), Dr S. Karthick Prabhu, Secretary, IMA Tamil Nadu, delivered a keynote address, providing valuable insights into the evolving public health system. He emphasised the importance of sustainability, inclusivity, and collaboration in shaping the future of healthcare in India.
Dr Prabhu highlighted that hospitals can achieve long-term success only when they operate on sustainable models that ensure both financial viability and quality patient care. He stressed the need for equal representation of small and medium hospitals in healthcare policy planning, as their contributions are crucial in maintaining a balanced and effective healthcare ecosystem. Without their inclusion, policies risk becoming skewed toward larger healthcare institutions, leading to gaps in accessibility and service delivery.
Dr S.KarthickPrabhu,Secretary,IMATamil Nadu
He also pointed out that Western models of hospital management are not entirely applicable in the Indian healthcare landscape. These
frameworks often overlook the critical role of small and medium hospitals, which serve a significant portion of the population. To build a system
Sanrad Infotech, Allied Medical, and Zota Healthcare along with Knowledge Partner Hospaccx.
The summit featured distinguished speakers who shared valuable insights on digital acceleration in hospitals, the future of healthcare delivery, and the evolving expectations of the next generation.
The event commenced with a Welcome Address by Express Healthcare, setting the stage for discussions and outlining the vision of the GenNext Hospital Summit 2025 series. This was followed by a lamp-lighting ceremony, symbolising an auspicious start to the gathering.
that truly caters to India's diverse healthcare needs, it is essential to develop management approaches that acknowledge and integrate these institutions.
Further, Dr Prabhu underscored the importance of collaboration across the healthcare industry. For healthcare chains to function seamlessly, stakeholders must work together to optimise resources, streamline operations, and enhance patient care. He also advocated for a standardised template and structured design in policy formulation and insurance bidding processes. A well-defined and uniform approach would help ensure transparency, efficiency, and better implementation of healthcare initiatives.
In conclusion, Dr Prabhu's address reinforced the need for a more inclusive, sustainable, and collaborative approach to healthcare management in India. His insights serve as a call to action for policymakers and industry leaders to build a future-ready healthcare ecosystem that caters to the needs of all stakeholders.
Panel discussion: Building a future-ready healthcare ecosystem
The healthcare landscape is undergoing a rapid transformation, driven by advancements in technology, shifting demographics, and evolving patient expectations. Recognising these changes, the GenNext Hospital Summit 2025 featured a thought-provoking panel discussion on the theme, "Building a Future-Ready Healthcare Ecosystem."
The esteemed panel comprised Dr S. Karthick Prabhu, Secretary, IMA Tamil Nadu; Prof. Dr Navin Gnanasekaran, Head of Clinical Services - Radiology & Interventional Radiology, Apollo Group of Hospitals; Dr Sai Surendar Mohan, Group Head - Emergency Medicine, Kamakshi Memorial
Hospital (Moderator); and Dr N. Kannan, Group Medical Director, Mehta Multispeciality Hospitals. Together, they shared valuable insights on how hospitals can navigate the evolving healthcare landscape while ensuring sustainability, efficiency, and equitable access to care.
One of the key discussions revolved around healthcare confidentiality, which remains a significant concern. With increasing digitisation, cybersecurity has become a top priority for hospitals to protect patient data and maintain trust. The panel stressed that implementing robust security protocols and data protection measures is critical in today's digital age.
Another vital aspect addressed was the training of nurses and paramedics to adapt to integrated technology and telemedicine practices. As digital tools become more prevalent in healthcare, frontline medical staff must be equipped with the necessary skills to effectively utilise teleconsultations, remote monitoring, and AI-driven diagnostics.
The panel also discussed the challenge of balancing equitable healthcare with sustainability while building a strong digital infrastructure. Investing in technology is crucial, but it should be done in a way that ensures affordability and accessibility, particularly in resource-limited settings.
Telemedicine emerged as a
key enabler in fostering collaborations between large multispecialty hospitals in urban areas and smaller healthcare facilities. By leveraging teleconsultations and remote expertise, major hospitals can extend their services to peripheral centres, ensuring that patients in smaller towns receive specialised care without the need for extensive travel.
To support such partnerships, the panel emphasised the role of government policies in encouraging Memorandums of Understanding (MoUs) between healthcare institutions. Strengthening peripheral healthcare services through structured collaborations can bridge healthcare gaps and en-
hance service delivery across regions.
Finally, the discussion highlighted that while technology is a game-changer, its appropriate and strategic implementation is essential. The panel warned against an overburden of expenditures due to excessive or redundant technological investments. Instead, hospitals should focus on cost-effective, scalable, and impactful solutions to enhance healthcare delivery.
The session concluded with a consensus that collaboration, innovation, and strategic policy-making are crucial in shaping a future-ready healthcare ecosystem that is secure, accessible, and sustainable for all.
L-R: Dr Sai Surendar Mohan,Group Head-EmergencyMedicine,Kamakshi Memorial Hospital (Moderator); Dr N Kannan,Group medical director,Mehta MultispecialityHospital: Prof Dr Navin Gnanasekaran,Head-clinical services radiology& interventional radiology,Apollo Group of Hospitals; Dr S.KarthickPrabhu,Secretary,IMATamil Nadu
Digital acceleration in hospitals
Dr Natesh B, COO, Lifeline Multispeciality Hospitals, shared his insights on digital acceleration and its transformative impact on healthcare. He emphasised that digital acceleration is not just about adopting technology but doing so at a significantly faster pace than traditional implementation timelines.
For medical administrators, digital acceleration brings a host of benefits, including increased operational efficiency, improved financial performance, enhanced decision-making, better regulatory compliance, scalability, and adaptability. By leveraging digital tools, hospitals can streamline workflows, optimise resource allocation, and ensure better patient management.
For medical professionals, the integration of digital
Dr Natesh B,COO,Lifeline MultispecialityHospitals
technologies facilitates seamless access to patient information, improved collaboration, and enhanced communication between multidisciplinary teams. This, in turn, leads to more informed clinical decisions and better patient outcomes.
From the patient's perspective, digital acceleration plays a crucial role in enhancing accessibility to healthcare services. With the rise of telemedicine, digital health records, and AIdriven diagnostics, patients can receive timely and personalised care, regardless of geographical barriers.
Dr Natesh underscored that embracing digital transformation is no longer optional but a necessity for building a futureready healthcare ecosystem that prioritises efficiency, connectivity, and patient-centric care.
Navaneeth Krishnan, CEO, Sanrad Infotech, emphasised the critical need for futureproofing healthcare IT by prioritising security, open-source solutions, and vendor neutrality. He highlighted that data security is no longer optional, as cyberattacks on hospitals have surged by 80 per cent in recent years. Protecting patient information and hospital systems from cyber threats must be a top priority for healthcare organisations.
Krishnan also outlined key technological advancements shaping the future of hospital IT infrastructure. He pointed out that AI-driven predictive analytics, fully encrypted telemedicine solutions, and flexible IT architectures
ranging from on-premises and hybrid models to cloud-based systems will define the next phase of digital transformation in healthcare. These technologies will enhance efficiency, security, and accessibility, ensuring hospitals can deliver high-quality care while safeguarding sensitive data.
Looking ahead, hospital IT infrastructure will play a pivotal role in defining the quality of patient care over the next decade. Krishnan urged healthcare leaders to invest in secure, scalable, and sustainable digital solutions that not only address current challenges but also pave the way for a more resilient and future-ready healthcare ecosystem.
Dr Abhishaanth Prabu, Medical Administrator, Be Well Hospitals, emphasised the importance of hospital design in ensuring optimal patient care while maintaining sustainability and efficiency. He highlighted that hospital design must prioritise patient outcomes without compromising operational effectiveness. A well-planned infrastructure can enhance both clinical efficiency and patient experience, ultimately leading to better healthcare delivery.
Dr Prabu stressed the need for sustainable infrastructure that supports sterile and clean clinical environments while integrating smart technology to enable faster diagnosis and treatment. By leveraging digital innovations, hospitals can
Strategic funding for hospitals-Fuelling growth
Venkata Phanidhar, Group CEO, Medway Hospitals, highlighted the financial challenges faced by private hospitals and the strategic approaches required to secure funding for growth and expansion. He pointed out that high capital expenditure (CAPEX), operational costs, regulatory hurdles, and intense competition make financing a critical concern for hospitals striving for sustainability and innovation.
Phanidhar emphasised that debt funding is a viable option when hospitals have stable cash flow to meet repayment obligations. This approach allows hospitals to retain full ownership and control, making it ideal for funding short-to-medium-term projects such as infrastructure upgrades, equipment pur-
streamline workflows, reduce waiting times, and improve overall patient management.
Another critical aspect of hospital design is its focus on infection control and patient privacy. Properly designed healthcare spaces can minimise the risk of infections through strategic layouts, air filtration systems, and controlled access areas. Additionally, ensuring patient confidentiality through thoughtful room configurations and soundproofing measures enhances the overall healing experience.
Dr Prabu concluded by emphasising that hospital design should be a seamless blend of functionality, safety, and patient-centric innova tion, paving the way for a futureready healthcare ecosystem.
chases, or service expansion.
For hospitals in a highgrowth phase, private equity and venture capital provide an alternative funding route. These sources offer significant capital infusion, enabling hospitals to expand their footprint, enhance clinical services, and invest in cutting-edge technologies. While this approach involves sharing ownership, it accelerates growth and strengthens market positioning.
Phanidhar underscored the importance of choosing the right funding strategy based on a hospital's financial health, growth stage, and long-term objectives. A well-structured funding model is key to ensuring sustainable expansion and enhanced patient care delivery in the evolving healthcare landscape.
Dr Abhishaanth Prabu,Medical Administrator,Be Well Hospitals
Venkata Phanidhar,Group CEO,MedwayHospitals
Design thinking and innovation in hospitals
R.A. Nadesan, Director, SRM Group, shed light on the role of design thinking in transforming hospital operations and patient care. He emphasised that design thinking, a human-centered approach to innovation, has been successfully applied across healthcare settings to enhance patient experience, streamline workflows, and improve overall hospital efficiency.
Nadesan outlined the five key steps of design thinkingempathise, define, ideate, prototype, and test which enable hospitals to tackle complex, illdefined, or evolving healthcare challenges. By deeply understanding patient and provider needs, healthcare institutions can develop innova-
R.A.Nadesan,Director,SRM Group
Infection control in next-gen hospitals
Dr Vijayalakshmi Balakrishnan, Senior Consultant in Infectious Diseases, Kauvery Hospital, emphasised that infection control strategies must be tailored to each healthcare facility rather than following a one-sizefits-all approach. She highlighted that every hospital has unique infrastructure, patient demographics, and operational workflows, necessitating individualised infection control protocols to ensure optimal patient safety.
Looking ahead, Dr Balakrishnan pointed out that future infections will primarily be aerosol-borne (droplet or airborne), contact-spread, or vector-borne. Additionally, in rare circumstances, infections may arise due to bioterrorism threats, making preparedness and proactive infection control strategies more critical than ever.
Dr Vijayalakshmi Balakrishnan,Senior Consultant in Infectious Diseases,KauveryHospital
She stressed the importance of continuous adaptation and innovation in infection prevention, urging hospitals to develop solu-
tions rooted in fundamental infection control principles. This includes rigorous hygiene measures, proper ventilation
systems, staff training, and realtime monitoring to combat the evolving threats of hospitalacquired infections.
tive solutions that improve service delivery and optimise resources.
He also highlighted the formula for achieving a competitive advantage in healthcare: Creating value (through design thinking) + capturing value (through efficiency methodologies) = competitive advantage. This approach ensures that hospitals not only innovate to meet patient needs but also implement strategies that enhance operational efficiency.
Nadesan concluded by reinforcing that design thinking is a crucial driver for innovation in healthcare, enabling hospitals to stay agile, patientfocused, and future-ready in an ever-evolving medical landscape.
Next-gen hospitals must integrate advanced infection control measures into their core operations
Dr Balakrishnan concluded by reinforcing that next-generation hospitals must integrate advanced infection control measures into their core operations, ensuring patient safety, staff protection, and overall healthcare resilience in an increasingly complex medical landscape.
Innovation as a solution to the AMR challenge
Dr Abdul Ghafur, Consultant in Infectious Diseases, Apollo Hospitals, Chennai highlighted the urgent and multifaceted challenge of Antimicrobial Resistance (AMR), emphasising that it is not merely a scientific concern but also a major socio-economic issue. AMR threatens global health security, increases healthcare costs, and limits the effectiveness of life-saving treatments, making it a critical area for immediate intervention and innovation.
Dr Ghafur stressed the importance of leveraging technology to combat AMR effectively. Advanced diagnostic tools, AIdriven surveillance systems, and digital prescribing solutions can help in tracking resistance patterns, reducing unnecessary antibiotic use, and ensuring more targeted treatments. He advocated for a multi-pronged strategy that integrates technology,
Dr Abdul Ghafur,Consultant in Infectious Diseases,Apollo Hospitals,Chennai
policy interventions, and public awareness to mitigate the AMR crisis.
Additionally, Dr Ghafur underscored the need for
innovative approaches in tackling AMR. Encouraging doctors to become innovators and entrepreneurs can lead to the development of new treatment
Encouraging doctors to become innovators can lead to the development of new treatment modalities, rapid diagnostics, and alternative therapies
modalities, rapid diagnostics, and alternative therapies. By fostering a culture of innovation within the medical community, healthcare can stay ahead of evolving microbial threats and build a sustainable, AMRresilient future.
Sustainabilityin healthcare supplychain and procurement
Vijay Roy, Assistant Vice President Group Materials and Purchase Kauvery Hospital emphasised the growing role of sustainability in healthcare supply chain management, highlighting how it is reshaping procurement strategies and industry partnerships. Sustainability in the supply chain is no longer just about product development; it has evolved into a knowledgedriven collaboration that fosters innovation, efficiency, and long-term transformation within the healthcare ecosystem.
The recent integration of sustainability principles into supply chain management has created an opportunity to reassess processes, materials, and operational methodologies from a fresh perspective. By embedding eco-friendly practices,
VijayRoy,Assistant Vice President Group Materials and Purchase KauveryHospital
optimising resource utilisation, and reducing waste, hospitals can achieve cost-effective and environmentally responsible procurement strategies.
Moreover, sustainabilitydriven procurement extends beyond economic benefits, incorporating social responsibility and environmental considerations into the value chain. This shift ensures that healthcare supply chains not only meet regulatory standards but also contribute to global sustainability efforts, promoting ethical sourcing, reduced carbon footprints, and improved healthcare accessibility.
Roy concluded by stressing that hospitals must prioritise sustainability as a core pillar of procurement strategies, paving the way for a resilient, responsible, and future-ready healthcare system.
HEALTHCARE IT
Our hospitals should adopt a multi-layered cybersecuritystrategy
Navaneeth Krishnan C, CEO,Sanrad Infotech,in an interaction with Express Healthcare, stresses the importance of healthcare ITinfrastructure in hospitals,highlights current challenges,and discusses the way forward
What is Sanrad Infotech’s vision for transforming hospital IT infrastructure?
Our vision is to build reliable and secure IT Infrastructure tailored for Indian hospitals, that seamlessly integrate modern hospital workflows with both legacy systems that may already be in place. We also specialise and have good partnerships with Industrybest vendors of HIS, PACS, video data archiving, surveillance intelligence, redundant networks, servers, clusters, data centers etc, while offering flexibility and control over critical data.
We focus on open-source solutions and hyper-converged infrastructure to offer costeffective and adaptable IT environments
What unique challenges do hospitals face in deploying high-speed networks, and how does your company address them?
Hospitals, especially in India, often deal with challenges like integrating new technology workflow with legacy systems, ensuring data security within local regulatory framework and maintaining uninterrupted patient care amidst resource constraints.
We address these by designing and deploying modular, scalable network solutions customised for the Indian healthcare environment, with robust security protocols, and vendor neutral approaches.
What innovations is Sanrad Infotech working on to enhance hospital network efficiency and cybersecurity? Are there
Strong encryption,network segmentation,regular security audits,and continuous monitoring are vital.Hospitals should implement robust access controls and comply with local regulatory standards
any plans to expand into international markets or new healthcare IT domains?
At Sanrad Infotech, we do continuous research on various tools and hardware, testing them inside out, to make sure they meet set standards for interoperability.
We are developing modular, scalable components that integrate well with advanced AI analytics, secure tunneling, and continuously test and refine scripts for hypervirtualised servers. We are also working on our own server line-up, collaborating
with high end component and hardware manufacturers. We are working on our own platform, utilising open source tools, to manage cross-vendor networks using a single interface.
We also do advanced network monitoring and predictive analytics for our clients to proactively identify vulnerabilities and optimise performance in real time.
And to answer the second question, while our primary focus is Indian healthcare sector, we are also exploring international opportunities.
With increasing cyberattacks on healthcare institutions, how should hospitals strengthen their IT defenses?
Our hospitals should adopt a multi-layered cybersecurity strategy, including vendorneutral network designs, robust firewalls and secure tunneling, and regular vulnerability assessments and penetration testing to identify and address potential threats. Network segmentation and hyper-virtualised servers are also crucial. Staff training on security awareness is essential, considering the diverse skill level often found in Indian hospitals.
What best practices should hospitals follow to protect patient data while maintaining network efficiency?
Strong encryption, network segmentation, regular security audits, and continuous monitoring are vital. Hospitals should implement robust access controls and comply with local regulatory standards.
Regular security audits, timely patch management, and continuous monitoring with advanced threat detection tools are essential to identify and address vulnerabilities. Ongoing staff training is crucial to maintain vigilance.
What are the key factors hospitals should consider when upgrading their IT networks?
A strong network backbone is fundamental. Hospitals must consider scalability, resilience, security, integration with existing systems (often a mix of old and new), and compliance with local regulations. A vendor-neutral, open-source approach can provide flexibility and cost savings.
What do you foresee as the next big disruption in healthcare IT?
I believe the convergence of on-premises and cloud based AI for diagnostics, telemedicine will be transformative. This will help address the challenges of access and affordability in Indian healthcare. I see more and more players in market who are working on open sourced platforms to make them better day by day. We need to focus on solutions that are scalable, cost-effective, and can be integrated with existing infrastructure, considering the unique needs of the Indian healthcare system. I have one thing to say to all the software vendors out there - Your software's primary purpose is to support medical experts in delivering quality patient care—never lose sight of that.
AI-led transformation in healthcare: Balancing innovation and patient privacy
Sankalp Gulati, Chief Data Science Officer,Eka Care emphasises that the digitisation of healthcare records represents more than just a shift from paper to pixels.It's fundamentally changing how healthcare providers interact with patient information
At the heart of India's healthcare revolution, artificial intelligence is emerging as a transformative force that promises to reshape how we approach patient care, medical documentation, and healthcare delivery. As the head of data science at the healthcare startup Eka Care, I've witnessed firsthand, GenAI technologies breaking down traditional barriers while raising pertinent questions about privacy and data security.
The digitisation of healthcare records represents more than just a shift from paper to pixels. It's fundamentally changing how healthcare providers interact with patient information. Our experience in developing an Electronic Medical Record (EMR) solution at Eka Care has shown that AI-powered systems can not only capture information more efficiently but also help reduce cognitive load of doctors in this process by surfacing medically meaningful insights.
In a country with doctorto-patient ratios far below optimal levels, a physician’s time is scarce. AI-enabled voice recognition and natural language processing solutions are pro ving rev olutionary in recording and managing patient information. Doctors can now spend more time with patients and less time on paperwork while maintaining comprehensive and accurate medical records.
Every innovation in healthcare AI must be viewed through the dual lenses of utility and privacy. Medical records contain our most personal information - our health history, medications, and private conversations with doc-
In a country with doctor-to-patient ratios far below optimal levels,a physician’s time is scarce.AIenabled voice recognition and natural language processing solutions are proving revolutionary in recording and managing patient information
tors. Protecting this information isn't just important; it's essential. In our development process, we've implemented several critical safeguards: First, we ensure data localisation, keeping sensitive health information within India's borders and complying with
domestic data protection regulations. Second, we follow data anonymisation techniques that allow us to train our AI models while protecting individual patient privacy. Third, we've implemented not only strong encryption for all data transmission and storage
but also an end-to-end encryption feature for storing medical records. Furthermore, Eka Care is one of the most prominent private implementers of ABDM, which entails following strong consent-based protocols for medical data exchange.
The future of AI in healthcare holds immense promise. We're seeing early success in automated diagnosis support, predictive analytics for patient outcomes, through doctor AI-assistants. However, each advancement must be balanced against ethical considerations and privacy concerns. As we push the boundaries of what's possible with AI, we must ensure that we don't compromise the fundamental trust between healthcare providers and their patients.
India's healthcare sector is uniquely positioned to benefit from these innova tions. Our large population and diverse healthcare needs provide both the imperative for inn ovation and the scale necessary to develop robust AI solutions. By carefully balancing technological advancement with privacy protection, we can create a healthcare system that is both more efficient and more humane.
The key to successful AI implementation in healthcare lies not just in the technology itself, but in how we deploy it. We must ensure that AI augments rather than replaces the human elements of healthcare. Our goal should be to empower healthcare providers with tools that enhance their capabilities while maintaining the essential human connection in medical care. As we look to the future, the path forward is clear: continue inn ovating, but do so with an unwavering commitment to patient privacy and data security. Only by maintaining this balance can we realise the full potential of AI in healthcare while preserving the trust that is fundamental to effective medical care.
RADIOLOGY
The rise of portable imaging devices in India
Portable imaging devices can bring diagnostic services closer to the patients,especially in rural and semi-urban areas.And hence,these devices are set to play a critical role in bridging India’s healthcare accessibility gap
Kalyani Sharma
The global healthcare landscape is undergoing a transformation, with portability, miniaturisation, and accessibility emerging as the guiding principles of medical imaging advancements. In India, where healthcare infrastructure remains unevenly distributed, the rise of portable imaging devices is proving to be a game-changer. These innovations ranging from handheld ultrasound systems and compact X-ray machines to portable MRI and CT scanners are not only bringing diagnostics closer to the patient but also reshaping healthcare delivery across urban and rural settings.
Amarket on the rise
According to Rohit Anand, Practice Head - Medical Devices, GlobalData, “Portable imaging is witnessing a rapid growth in India on account of increased healthcare expenditure, coupled with a rise in chronic diseases, and the demand for accessible diagnostic solutions. According to GlobalData, the Diagnostic Imaging devices market in India is projected to reach over $7 billion by 2033 at a compound annual growth rate (CAGR) of ~7 per cent. In 2024, India accounted for around 20 per cent of the Asia-Pacific (APAC) Diagnostic Imaging devices market.
Latest technological advancements
Recent years have witnessed significant breakthroughs in portable imaging technology, enhancing diagnostic capabilities and making these devices more efficient and accessible.
“Portable imaging devices have seen significant advancements in recent years, thanks to state-of-the-art technologies. Notable developments include the integration of artificial in-
telligence (AI) for more accurate image analysis, miniaturisation for easy portability across various imaging modalities, enhanced wireless connectivity for seamless datasharing, and telemedicine inte-
Advanced techniques such as 3D/4D imaging and improved detectors have improved diagnostic capabilities. Additionally,there is a growing focus on point-of-care solutions,bringing imaging directly to patients and improving healthcare accessibility
Rohit Anand Practice Head - Medical Devices, GlobalData
Portable imaging devices provide a practical solution by delivering diagnostics directly to patients, minimising travel,and ensuring timely care
Ayush Singh Practice Member in Healthcare and Lifesciences, Praxis Global
Organisations and healthcare providers that can supply dependable, cost-effective,and locally manufactured solutions customised to meet region specific requirements are likely to gain a competitive advantage in this developing market
Dr D.Karthikeyan Director and Sr.consultant-Department of Radiology & Imaging sciences, SIMS,Chennai
SEVERALMACRO TRENDS UNDERPIN THIS MARKET EXPANSION
◆ Telemedicine integration: India's eSanjeevani telemedicine platform (linking 155,000+ rural health centers under Ayushman Bharat) and the collaborative digital diagnosis systems are creating demand for connected portable devices in remote settings
◆ AI and cloud solutions: Enhanced data analysis and diagnostic precision at the pointof-care are becoming feasible with AI-powered Portable CT, Portable ultrasound,and Portable X-ray,analysing imaging data more effectively, assisting healthcare providers in identifying conditions such as fractures or tumors with greater precision
◆ Demographic shifts: With India's aging population growing (population aged 60+ expected to reach ~200 million by2030) and rising chronic disease prevalence,accessing hospitals for regular imaging is often challenging due to mobilityand geographic barriers.Portable imaging devices provide a practical solution bydelivering diagnostics directlyto patients, minimising travel,and ensuring timelycare
◆ Operational efficiency: Reduced training requirements for some portable devices can alleviate workforce constraints
gration. Advanced techniques such as 3D/4D imaging and improved detectors have improved diagnostic capabilities. Additionally, there is a growing focus on point-of-care solutions, bringing imaging directly to patients and improving healthcare accessibility. Portable MRI and CT scanners have also seen improvements in diagnostic performance. The advent of photon counting technology is set to transform this field by enhancing resolution and contrast, as well as by reducing radiation exposure, similarly, the introduction of light and compact MRI magnets are other notable technological advancements in the
field of diagnostic imaging.”
“The clinical impact of portable imaging is significant. It enables early disease detection, leading to timely interventions and improved patient outcomes. By allowing imaging to be performed at the bedside, there is less risk associated with patient transfers and increased patient comfort”, explains Anand
Challenges in adoption
The introduction of portable imaging equipment in India is still a work in progress. Despite the promising advancements, the widespread adoption of portable imaging devices in India faces multiple hurdles. Cost remains a significant barrier, with high initial investments required for procurement and maintenance.
Dr D. Karthikeyan, Director and Sr. consultant-Department of Radiology & Imaging sciences, SIMS, Chennai shares, “challenges to widespread adoption include a scarcity of trained professionals, insufficient power supply, poor logistics, and limited maintenance support, which lead to operational hurdles. Additionally, portable devices require routine calibration and servicing, which can be difficult in remote locations. Organisations and healthcare providers that can supply dependable, cost-effective, and locally manufactured solutions customised to meet region specific requirements are likely to gain a competitive advantage in this developing market.”
Danish Aini, General Manager-Clinical Engineering, Artemis Hospitals, points out, “Regulatory issues, from the point of ensuring safety, precision, and compliance with radiation exposure standards, remain a key challenge. In India, medical image devices are expected to comply with standards laid by the central drugs standard control organisation and the atomic energy regulatory board for radiation devices. Data safety and patient protection are also ongoing challenges, with cloud based solutions for imaging rising in popularity. To address these hurdles, industry players need to concentrate on affordable innovations, regulatory simplification, and formal training programs. Resolution of these issues will enhance adoption, eventually enhancing diagnostic access, early disease identification, and patient outcomes in various healthcare environments.”
As these devices become more affordable and integrated into digital healthcare ecosystems,they will play a crucial role in bridging healthcare gaps, especially in underserved regions
Kabir Mahajan COO,
Mahajan Imaging and Lab
Regulatory issues,from the point of ensuring safety,precision,and compliance with radiation exposure standards,remain a key challenge
Danish Aini General Manager-Clinical Engineering, Artemis Hospitals
As hospitals face challenges related to space,availability of beds,and qualified medical staff,portable imaging will help decongest hospitals by enabling preliminary diagnostics at home
Dr Aashish Chaudhry
Managing Director and Senior Consultant & Head, Department of Orthopaedics & Joint Replacement, AakashHealthcare
The introduction of portable imaging equipment in India is still a work in progress.Despite the promising advancements,the widespread adoption of portable imaging devices in India faces multiple hurdles
Portable imaging devices can bring diagnostic services closer to the patients, especially in rural and semi-urban areas. And hence, these devices are set to
5G-enabled telemedicine, and cost-effective manufacturing paving the way for widespread adoption.
“As these devices become more affordable and integrated into digital healthcare ecosystems, they will play a crucial role in bridging healthcare gaps, especially in underserved regions. Government initiatives promoting digital health and public-private partnerships will further accelerate market penetration. Already multiple projects are ongoing for, AI based screening for tuberculosis on X-rays in hundreds of remote districts of India. Similar screening can be enabled for breast cancer, lung cancer and other non-communicable diseases. In the coming years, portable imaging will shift the paradigm from hospital-centric to patient-centric diagnostics, making early detection and preventive care more accessible. This transformation will ultimately lead to improved healthcare equity and better patient outcomes nationwide.”
Dr Aashish Chaudhry, Managing Director and Senior Consultant & Head, Department of Orthopaedics & JointReplacement, AakashHealthcare states, “As hospitals face challenges related to space, availability of beds, and qualified medical staff, portable imaging will help decongest hospitals by enabling preliminary diagnostics at home. This shift will allow hospitals to focus on tertiary care, while primary diagnostics can be managed through home healthcare models.”
Wayforward
play a critical role in bridging India’s healthcare accessibility gap.
Kabir Mahajan, COO, Mahajan Imaging and Lab believes that the future of portable imaging in India is promising, with advancements in AI,
With the increasing adoption of AI-driven diagnostics, better connectivity, and a shift towards preventive healthcare, the portable imaging market in India is poised for exponential growth. While challenges remain, ongoing advancements and strategic investments will ensure that these devices become a cornerstone of modern healthcare, making quality diagnostics more accessible and efficient than ever before.
Bridging healthcare gaps via an omnichannel approach
Mohit
Sood, Regional Managing Principal,ZS
stresses that omnichannel engagement not only reduces medical errors and improves patient satisfaction but also empowers individuals to take ownership of their health
India has made significant strides in healthcare, yet challenges persist due to its vast and diverse population. Healthcare infrastructure development, particularly in tier two and three cities, struggles to keep pace while government expenditure on healthcare, at 2.9 per cent, lags countries such as the US (18.9 per cent) and China (10.1 per cent).1 The healthcare system faces many obstacles in resource allocation and ensuring equitable access across the nation. Against such a backdrop, a promising solution leveraging technology to embrace a patient-centric approach through omnichannel engagement has recently emerged.
The approach resonates more since the traditional reactive model of healthcare, where patients seek help only when illness strikes, is no longer sufficient. Today, patients are more informed and demand personalised and proactive care. This is where omnichannel engagement proves valuable. It goes beyond offering multiple communication channels, creating an integrated experience across online and offline touchpoints through the entire patient journey.
Current healthcare landscape: Afragmented experience
In today's healthcare landscape, a troubling gap exists between expectations and reality. ZS Future of Health Report highlights a concerning trend: Patients are not getting what they need from healthcare systems. Dissatisfaction runs deep, spanning overall health outcomes, appointment accessibility, diagnosis timelines and the crushing weight of medical costs. This issue is further exacerbated by discrepancies between patient
experiences and physician perceptions, coupled with a lack of seamless information flow among healthcare providers. The consequences include increased risk of medical errors, reduced patient engagement and growing frustration with the healthcare system.
Omnichannel: A patient-centric solution
Omnichannel engagement offers a powerful strategy to address these challenges. By providing consistent and highquality care across all platforms, it meets healthcare professionals and patients where they are. This approach not only facilitates real-time data sharing and collaboration but also enhances the overall patient experience.
For India, some key omnichannel strategies include:
◆ Leveraging teleconsultations, telemedicine and remote patient monitoring to ad-
dress the critical shortage of healthcare facilities, particularly important in a country where the doctor-population ratio is 1:834.2
◆ Development of multilingual patient portals and mobile apps with user-friendly interfaces to cater to India's diverse linguistic landscape.
◆ Integration of traditional healthcare providers, such as Accredited Social Health Activists (ASHAs), into the digital ecosystem to bridge the gap between traditional and modern healthcare delivery.
◆ Harnessing government initiatives such as the Ayushman Bharat Digital Mission to facilitate data sharing and interoperability across healthcare systems.
◆ Implementation of centralised patient portals offering comprehensive medical history access, appointment scheduling and secure messaging features.
◆ Deployment of AI-powered chatbots to answer common
questions and provide basic health information.
◆ Development of online patient education modules to improve health literacy and promote preventive healthcare practices, which is crucial in India where the healthy life expectancy at birth is only 58.1 years, as per WHO.3
AI: Catalyst for healthcare transformation
AI is transforming healthcare by enhancing care outcomes, productivity and efficiency. Its applications span medical diagnosis, data management, treatment planning and early disease detection. For India, with its low bed-to-patient ratio of 0.6 per 10004, AI can bridge critical gaps, especially in resource-constrained settings. India's projected AI expenditure of $11.78 billion by 20255 and NITI Aayog's initiatives in AI-powered diabetes detection and eye care screening underscore this potential.
AI is poised to transform the patient experience, functioning as a virtual co-caretaker and opening new frontiers in medical research. In the field of clinical trials, AI is tackling significant challenges such as patient enrolment, site selection, operational inefficiencies and patient retention.
Despite being in its early stages, Generative AI (Gen AI) is advancing patient engagement and clinical decisionmaking by analysing unstructured data and synthesising complex information into easily understandable formats. It has also accelerated delivery efficiency in healthcare. For instance, it identified a potential Idiopathic Pulmonary Fibrosis (IPF) treatment in 21 days, vastly outpacing conventional drug discovery timelines.
Benefits of omnichannel engagement
Omnichannel engagement not
only reduces medical errors and improves patient satisfaction but also empowers individuals to take ownership of their health. Increased access to information leads to better treatment adherence, while data-driven insights enable timely interventions. By streamlining administrative tasks and optimising resource allocation, it makes healthcare more cost-effective and efficient. Nevertheless, data privacy concerns, the need for robust digital infrastructure and the training of healthcare professionals in new technologies are hurdles that need to be addressed.
In India, where digital literacy varies widely, ensuring equitable access to these advanced healthcare solutions is crucial. We must be cautious not to create a new form of healthcare disparity where only the technologically savvy can benefit from these advancements. It requires a concerted effort from all stakeholders–healthcare providers, policymakers, technology companies, consulting firms and patients. Only then will the omnichannel approach to healthcare, powered by AI and driven by a commitment to improved patient outcomes, represent the future of medicine.
People power: The keyto transforming healthcare capabilitycenters in India
Minal Chaterjjee, Founder and Chief Communication Officer,Goodwill Communications and Communication Consultant,Medtronic stresses that to unlock the full potential of healthcare GCCs, organisations must move beyond transactional engagement and adopt a transformational approach
India has rapidly emerged as a preferred destination for Global Capability Centers (GCCs) and R&D hubs of leading multinational healthcare companies. The Indian medtech market is expected to reach $50 billion by 20301. While cost-effectiveness and operational efficiency remain the primary drivers of these expansions, the real engine of success is the people who power these centers.
GCCs are human capital-intensive units. These thrive not just on operational efficiency but on their ability to attract, engage, and retain top talent. In today’s dynamic landscape, a people-first approach is essential. Employee mindshare is just as crucial as market share.
While many companies invest in organisational health surveys, newsletters, and town halls, the real question remains—are these efforts enough to build a strong employer brand, retain top talent, and drive innovation?
Beyond skills: Finding purpose
A critical challenge that many healthcare GCCs face is not just a skills gap, but an engagement gap. Employees, particularly those in technical and analytical roles, often operate in silos, disconnected from the broader mission of their organisations. They may log in, code, and log out, often unaware of the profound impact their work has on the end user. Be it a patient receiving better healthcare or a doctor making a life-saving decision, without this connection, work can feel transactional rather than transformational.
This challenge is even more pronounced in India, where financial security and material comforts remain a priority, particularly for the 25-35 age demographic that dominates these centers. Employees are often more concerned about immediate benefits including travel allowances, lunch coupons, and
salary hikes than the grander vision of their organisation’s work. While these incentives are necessary, they alone cannot drive engagement or innovation.
However, there is a silver lining. One aspect that employees across the board value is learning and development. Whether through leadership talks, AI tool training, or exposure to global best practices, employees appreciate opportunities to upskill. After all, much of what they need to succeed is not taught in formal education and it is learned on the job. A company’s true competitive edge lies in the growth opportunities it offers its workforce.
1.High-impact workforce solutions
To unlock the full potential of healthcare GCCs, organisations must move beyond transactional engagement and adopt a transformational approach. Here’s how:
Connection before communication
Employees struggle to connect with the organisation's larger mission when impact storytelling is occasional and topdown rather than continuous and immersive. Leadership often shares broad success stories, but employees fail to see how their individual contributions fit into the bigger picture.
Internal messaging needs more depth and emotional appeal to be truly effective. Instead of relying solely on emails and presentations, organisations should create immersive experiences.
◆ Virtual patient simulations can help developers and engineers witness the real-time impact of their solutions.
◆ Reverse shadowing programs can provide firsthand exposure to how their work is used in hospitals, research labs, or clinics.
◆ Regular stakeholder roundtables with patients, healthcare providers, and technology users can bring impact to life, making
the connection between work and purpose more tangible.
2.Hyper-personalised learning and career growth
Employees who stay longer in their roles develop deeper expertise, drive meaningful change, and contribute to sustained improvements. However, when skilled employees leave, organisations lose invaluable knowledge that is often difficult to replace. Retaining top talent requires more than just competitive salaries, it demands a strong commitment to personalised career development.
Millennials, the largest segment of today’s workforce, actively seek leadership training, reinforcing the need for tailored learning experiences. Instead of a one-size-fits-all approach, training programs should be customised to align with individual career aspirations, ensuring long-term engagement and growth:
◆ Create mentorship programs where senior professionals guide young talent.
◆ Offer certification programs in emerging fields like digital health, AI in diagnostics, and healthcare data analytics.
◆ Provide AI-driven learning recommendations based on career trajectories.
3.Evolving recognition beyond transactions
People appreciate recognition that is immediate, personalised, and meaningful, instead of generic "employee of the month" awards. Most recognition efforts
drive initial enthusiasm but fail to sustain engagement over time offering points and digital badges without linking them to career advancement, learning, or real-world perks.
Companies can:
◆ Move beyond leaderboards and implement “impact-based” recognition where employees are awarded for contributions that directly impact patient outcomes, product innovation, or user experience.
◆ Introduce "hidden rewards" and unpredictability to maintain excitement—e.g., surprise project opportunities for highperforming employees.
◆ Make peer-driven recognition more prominent so that praise isn't always top-down.
4.Making everyemployee a stakeholder
A study by Gallup found that employees who see meaning in their work are 3x more likely to stay engaged2. By making employees feel like active stakeholders in healthcare innovation, organisations can significantly boost motivation.
Companies can:
◆ Share real-world case studies of how their work impacts healthcare outcomes.
◆ Use storytelling to bring patient journeys to life, connecting employees to the bigger picture.
◆ Introduce cross-functional projects where coders interact with doctors, researchers, or end users to understand how their contributions make a difference.
5.Encouraging innovation without fear
On several occasions, despite having innovation challenges and incubation programs, employees hesitate to take risks due to company culture constraints. There are times when innovation is encouraged, but failure is still penalised, discouraging employees from experimenting with bold ideas. In certain cases, R&D teams often drive innovation, while other
Sometimes Employees are expected to innovate but are already stretched thin with deliverables, leaving little bandwidth for creative problem-solving.
Companies can:
◆ Implement a "failure budget", where teams are allocated resources specifically for risk-taking and experimentation, without consequences for failure.
◆ Democratise innovation by encouraging "everyday innovation", where small process improvements are valued just as much as groundbreaking product ideas.
◆ Introduce cross-functional innovation pods by bringing together IT, data science, healthcare professionals, and business leaders to solve real-world challenges.
The future of healthcare GCCs lies in people India’s healthcare GCCs have immense potential to drive global innovation, but their success hinges on how well they engage, inspire, and develop their workforce. Organisations can build a culture where employees don’t just work for a paycheck but for a larger cause, one that saves and improves lives.
After all, just as a strong immune system keeps the body resilient, a well-engaged workforce keeps an organisation thriving. That’s how GCCs can move beyond transactional engagement and create transformational workplaces.
The concept of Medicall Expo was born out of a pressing need in the Indian healthcare sector
As of 2025,Medicall Expo has completed 40 editions since its inception.The 41st edition is set to take place from April 5-7,2025,at the Hitex Exhibition Centre in Hyderabad
Introduction
Medicall Expo, India's premier B2B medical equipment exhibition, has established itself as a leading platform for showcasing medical innovations, healthcare technologies, and hospital infrastructure. The concept of Medicall Expo was born out of a pressing need in the Indian healthcare sector.
Dr Manivannan S, Managing Director, Kauvery Hospital, realised the challenges faced by small and medium-sized hospitals in procuring medical equipment and services. To bridge this gap, he envisioned a platform where medical equipment manufacturers could directly interact with healthcare decisionmakers. This vision materialised in 2006 with the first edition of Medicall in Chennai, featuring 80 exhibitors and attracting 2,500 visitors.
Growth and expansion (2007-2015)
Building on the success of its inaugural event, Medicall expanded rapidly. Between 2007 and 2009, the number of exhibitors increased from 120 to over 250, while visitor attendance grew from 3,500 to 5,200. The expo quickly gained a reputation as a must-attend event for medical professionals and hospital administrators.
By 2010, Medicall Expo had begun to attract international attention, with over 400 exhibitors from China, Germany, Taiwan, and England participating. The visitor count also surged to 8,000, underscoring the event’s rising popularity. Recognising the importance of innovation, Medicall introduced the Healthcare Innovation Awards in 2011, celebrating groundbreaking medical advancements. That year, the expo hosted over 430 exhibitors and 8,500 visitors.
In 2013, the Brainstorm Medicall conferences were intro-
In 2024,the Mumbai edition,hosted at the Bombay Exhibition Centre,brought together industry leaders,healthcare professionals,and technology providers.The event emphasised advancements in medical equipment and hospital infrastructure
duced, providing a dedicated platform for knowledge-sharing among healthcare professionals. This edition witnessed 530 exhibitors and over 10,000 visitors, solidifying Medicall's status as a premier event in the industry. By 2015, the expo had expanded beyond Chennai, making its debut in Mumbai with 200 exhibitors and 7,500 visitors.
Diversification and nationwide presence (2016-2019)
The following years saw Medicall diversifying its offerings and extending its reach. In 2016, an exclusive IT pavilion was introduced, reflecting the growing role of digital healthcare solutions. That same year, the expo expanded to Delhi, hosting 300 exhibitors and attracting 10,000 visitors.
In 2018, Medicall ventured into Hyderabad, while the Chennai edition featured an impressive 800 exhibitors and 16,500 visitors. By 2019, the event had become a truly international platform, with exhibitors from over 20 countries participating.
The Medicall Academy was also launched this year, providing industry leaders and hospital administrators with insights into best practices and emerging trends in healthcare management.
Challenges and adaptation during the pandemic (2020-2021)
The COVID-19 pandemic posed unprecedented challenges for
large-scale events worldwide. However, Medicall adapted swiftly, launching India’s first virtual medical expos focused on hospital infection control, telemedicine, home healthcare, and remote monitoring. Despite the limitations of physical gatherings, the virtual editions featured 55 exhibitors and over 1,000 visitors, ensuring continuity in industry interactions.
As the world adapted to the new normal, Medicall resumed in-person events with its 27th edition in Chennai in 2021. This event played a crucial role in supporting Indian manufacturers and dealers, featuring 450 exhibitors and 13,000 visitors.
Recent developments and future prospects (2022-2025)
In 2022, Medicall was successfully organised in Hyderabad, with 300 exhibitors and 6,000 visitors. The event continued to emphasise cutting-edge innovations, from AI-driven diagnostics to advanced surgical technologies.
In 2024, the Mumbai edition, hosted at the Bombay Exhibition Centre, brought together industry leaders, healthcare professionals, and technology providers. The event emphasised advancements in medical equipment and hospital infrastructure, offering attendees insights into cutting-edge technologies and solutions with over 303 exhibitors, 17,000 visitors.
Hyderabad edition, taking
place at the Hitex Exhibition Center, highlighted regional healthcare needs and solutions with over 215 exhibitors, 8,000 visitors. The event featured interactive sessions and product demonstrations, providing a platform for knowledge exchange and networking among healthcare stakeholders.
The Chennai edition stood out as a flagship event, featuring over 532 exhibitors and drawing more than 20,000 professional visitors. Attendees had the opportunity to explore a vast array of over 10,000+ products, reflecting the expo's commitment to showcasing the latest innovations in healthcare.
Delhi edition, held at the Pragati Maidan attracted a substantial number of 464 exhibitors and 20,000 visitors, underscoring the city's strategic importance in the healthcare sector. The event featured specialised seminars and workshops, focusing on emerging trends and challenges in the medical field.
As of 2025, Medicall Expo has completed 40 editions since its inception. The 41st edition is set to take place from April 5-7, 2025, at the Hitex Exhibition Centre in Hyderabad. This milestone event is expected to feature more than 300 exhibitors showcasing more than 10,000+ hospital products and services at display.
Brainstorm Medicall seminars
In 2013, the Brainstorm Med-
icall conferences were introduced, providing a dedicated platform for knowledge-sharing among healthcare professionals.
The highlight of Medicall is its engaging seminars and workshops, designed to be highly interactive rather than one-directional or purely instructional. Great care is taken to ensure dynamic discussions, making them responsive and insightful.
Brainstorm Medicall features an Interactive Healthcare Intelligentsia, delivering valuable insights in a concise and impactful manner.
Medicall serves as the perfect intersection where medicine meets management. Over the years, the event has hosted over 1,000 seminars on a wide range of topics.
Medicall innovation awards
The Medicall Innovation Awards are among the most prestigious and widely discussed accolades in India's healthcare industry. These awards are designed to recognise, showcase, and promote groundbreaking innovations in the healthcare sector.
With over 160 entries from across the globe, the awards have earned a strong reputation for their credibility and impact. To ensure variety and diversity, Medicall introduces a new award category each year, replacing an existing one, keeping the recognition fresh and relevant.
Conclusion:
Medicall Expo has grown from a regional trade fair into an internationally recognised event that plays a pivotal role in the global healthcare industry. By fostering collaborations, showcasing innovations, and providing a platform for knowledge exchange, it continues to shape the future of medical technology and healthcare services.
HEALTHCARE TRACKER
The billion dollar industry: Howsilicone is transforming medical device industry
This article delves into why silicone is revolutionising healthcare,how it compares to conventional materials,and the emerging trends that make it a billion-dollar investment opportunity for manufacturers,healthcare providers,and investors alike
The medical device industry is evolving at an unprecedented pace, driven by advancements in technology, increased regulatory standards, and a growing demand for patient-centric solutions. At the core of this transformation is medicalgrade silicone—a versatile, biocompatible, and highly durable material that is redefining the standards of safety, efficiency, and innovation in healthcare.
adoption in areas such as prosthetics, wound care, and bioelectronic applications. With the rise of customized healthcare solutions, wearable medical devices, and 3D-printed implants, silicone is playing a pivotal role in shaping the future of medicine.
Whysilicone?
The science behind its medical application
● Superior biocompatibility &
From ophthalmology and gynecology to respiratory care and surgical applications, silicone has become a material of choice for medical manufacturers due to its exceptional properties, including flexibility, sterility, and resistance to extreme conditions.
Unlike traditional materials such as latex, PVC, or metal, silicone offers superior biocompatibility, hypoallergenic properties, and longevity, making it ideal for long-term implants, drug delivery systems, and minimally invasive medical procedures.
Market research indicates that the global medical-grade silicone industry is set for exponential growth, with increasing
safety
Silicone is chemically inert, meaning it does not react with human tissues or bodily fluids, making it highly biocompatible. Unlike PVC and latex, which may trigger allergic reactions or toxic leaching, silicone offers a safe alternative for long-term medical use. Regulatory bodies such as the FDA and CE have approved silicone for a wide range of applications, from implants to external devices.
● Exceptional flexibility and durability
Silicone’s molecular structure, featuring strong Si-O-Si bonds, grants it high durability and resistance to mechanical stress. It retains its properties
across extreme temperature ranges (-60°C to 250°C), making it ideal for critical care applications such as ventilator circuits and infusion therapy.
● Sterilisation and hygiene advantages
Medical-grade silicone is resistant to bacterial growth and can withstand multiple sterilization methods, including autoclaving, gamma irradiation, and ethylene oxide sterilization. This makes it particularly useful for reusable medical devices such as wound drains and surgical implants.
● Chemical and fluid resistance
Silicone is non-reactive with bodily fluids, medications, or disinfectants, ensuring product longevity in medical environments. This chemical stability is crucial for drug delivery systems and catheters, which require consistent performance over extended periods.
● Hypoallergenic and soft texture
Silicone’s soft texture enhances patient comfort, making it the material of choice for menstrual cups, pessary rings, and respiratory masks. Its hypoallergenic nature further enhances its suitability for prolonged skin contact.
Silicone’s role in medical innovations
Ophthalmic devices: Silicone phaco sleeves enable precision in cataract surgeries, while silicone scleral buckles enhance treatment options for retinal detachment.
Respiratory and critical care: Silicone components in ventilator circuits, CPAP devices, and oxygen masks provide enhanced comfort and improved performance.
● Women’s health and Gynecology
Menstrual cups: Offering a sustainable alternative to disposable hygiene products.
Pessary rings: Providing nonsurgical support for pelvic organ prolapse.
Kegel balls: Assisting in pelvic floor strengthening and postpartum recovery.
◆ Intravenous and infusion therapy: Silicone is widely used in catheter tubes, infusion pumps, and needle- free connectors, ensuring safe drug administration
◆ Wound care and surgery: Silicone-based wound drains and dressings promote faster healing while reducing infection risks.
Howsilicone is disrupting traditional medical materials
◆ Silicone vs. plastic: The shift toward safer alternatives
Unlike PVC and latex, which may contain phthalates and BPA, silicone is free from harmful additives, making it safer for medical applications.
◆ Silicone vs. metal: A revolution in medical implants
While metal implants are strong, they are often rigid and heavy. Silicone, on the other hand, provides greater flexibility and adaptability, leading to improved patient experiences.
◆ Disposable vs. reusable
medical devices: A cost-benefit analysis
With growing concerns over medical waste, silicone-based reusable devices are becoming the preferred choice due to their long lifespan and environmental benefits.
The regulatorylandscape: Is silicone the newindustrystandard?
◆ FDA & CE approvals for silicone-based devices
Medical-grade silicone has secured regulatory approvals across major global markets, reinforcing its reliability in healthcare.
● The growing push for sustainable medical solutions
Silicone aligns with global sustainability initiatives by reducing dependency on singleuse plastics in medical settings
Challenges in adoption
◆ Higher manufacturing costs: Initial costs are higher compared to conventional materials like plastics.
◆ Standardisation issues: Ensuring consistent quality across medical-grade silicone products remains a challenge.
Market growth: The billion-dollar potential
The global medical-grade silicone market was valued at approximately $1.6 billion in 2024 and is projected to grow at a CAGR of 7.5 per cent from 2025 to 2030. This growth is fueled by increasing demand in biomedical devices, prosthetics, and drug delivery systems
What’s driving the demand?
◆ Aging population: With a growing elderly demographic, there is a higher demand for prosthetics, orthopaedic im-
HEALTHCARE TRACKER
plants, and long-term medical solutions.
◆ Minimally invasive surgeries: The rise in laparoscopic and robotic surgeries has increased the need for flexible, biocompatible materials like silicone.
◆ Sustainability & reusability: The healthcare industry is shifting towards reusable devices to reduce environmental
◆ Breakthroughs in bioelectronics: Silicone-based neural interfaces are facilitating braincomputer communication, potentially transforming treatments for neurological disorders.
◆ Expansion in new medical fields: Silicone is expanding into emerging areas such as oncology, regenerative medicine, and
waste, further boosting silicone’s appeal
Whyinvestors and medical giants are betting on silicone
◆ Higher profit margins: Although the initial production cost of silicone devices is higher, their durability and reusability lead to long-term cost savings.
◆ Customisation demand: The ability to tailor silicone products to patient needs is attracting attention from medical manufacturers.
◆ Regulatory approvals: Increasing acceptance of siliconebased medical devices by global regulatory bodies ensures market stability and growth.
Future outlook: What’s next for silicone in healthcare?
◆ Smart medical devices: Silicone is being integrated into wearable biosensors and drug delivery patches, enhancing real-time patient monitoring.
◆ Personalised & 3D-printed silicone medical devices: Advancements in 3D printing are enabling the creation of customised prosthetics and implants, revolutionising patient care.
solutions. With the industry poised for substantial growth, companies investing in medicalgrade silicone are well-positioned for long-term success.
Embracing silicone innovation today could unlock a billiondollar opportunity in the evolving landscape of healthcare.
Whychoose AMI Polymer for silicone medical products?
At AMI Polymer Pvt Ltd, we are committed to delivering worldclass silicone medical solutions that meet the highest industry standards. With years of expertise in manufacturing biocompatible, high-performance, and precision-engineered silicone products, we have established ourselves as a trusted partner in the medical device industry.
● Industry expertise and proven track record
With a strong presence in ophthalmology, gynecology, respiratory care, gastroenterology, and critical care, we have devel-
robotic-assisted surgeries, highlighting its versatility and potential.
Conclusion Silicone has transitioned from an alternative material to a fundamental necessity in modern medical devices. Its unparalleled biocompatibility, durability, and flexibility make it indispensable for next-generation healthcare
oped a comprehensive range of medical-grade silicone products that cater to diverse healthcare applications. Our expertise in customized solutions makes us the preferred choice for hospitals, healthcare providers, and medical manufacturers worldwide.
● Certified quality and compliance
At AMI Polymer, we prioritise safety, performance, and regulatory compliance. Our silicone products are manufactured in state-of-the-art facilities, following strict GMP (Good Manufacturing Practices) and adhering to international FDA, CE, and ISO 13485 standards.
We ensure:
◆ 100 per cent biocompatibility for patient safety
◆ Non-toxic, hypoallergenic, and durable materials
◆ Full compliance with global medical regulations
● Advanced R&D and customisation capabilities
Innovation drives us. Our dedicated research and development (R&D) team collaborates with healthcare professionals to create customised silicone solutions that enhance performance, patient comfort, and clinical efficiency. Whether it's silicone tubing, prosthetics, or implantable devices, we offer precision-engineered products tailored to specific medical requirements.
◆ Sterilization compatibility –resistant to autoclaving, gamma radiation, and chemical disinfection
◆ Fluid & chemical resistance –ensuring product integrity in medical environments
◆ Comfort & safety – soft texture for long-term patient use (ideal for pessary rings, menstrual cups, and catheters)
● Cost-effective and sustainable medical solutions
With the healthcare industry moving toward sustainability and reusable medical devices, AMI Polymer provides long-lasting, eco-friendly, and cost-efficient silicone alternatives. Our products help:
◆ Reduce medical waste by replacing disposable plastic alternatives
◆ Lower long-term costs with durable, reusable solutions
◆ Improve operational efficiency in healthcare settings
● Trusted by industry leaders
Our silicone components are widely used by leading medical device manufacturers, hospitals, and research institutions. We continue to build strong partnerships by delivering highquality, reliable, and innovative silicone solutions that meet the evolving needs of modern healthcare.
● Reliable partner in medicalgrade silicone
At AMI Polymer, we are more than just a manufacturer—we are your trusted partner in healthcare innovation. By choosing us, you gain:
◆ Unparalleled product quality
◆ Cutting-edge R&D and customization
◆ Regulatory-compliant medical solutions
◆ Global reach and customercentric service
Are you ready to upgrade your medical devices with superior silicone solutions? Partner with AMI Polymer today and be part of the billion-dollar transformation in healthcare!
Wound Care & Surgery
Silicone-based wound drains and dressings promote faster healing while reducing infection risks
Superior Biocompatibility & Safety
Silicone is chemically inert, meaning it does not react with human tissues or bodily fluids, making it highly biocompatible. Unlike PVC and latex, which may trigger allergic reactions or toxic leaching, silicone offers a safe alternative for long-term medical use.
Regulatory bodies such as the FDA and CE have approved silicone for a wide range of applications, from implants to external devices.
Exceptional Flexibility & Durability
Silicone’s molecular structure, featuring strong Si-O-Si bonds, grants it high durability and resistance to mechanical stress. It retains its properties across extreme temperature ranges (-60°C to 250°C), making it ideal for critical care applications such as ventilator circuits and infusion therapy.
HEALTHCARE TRACKER
Wipro GE Healthcare unveils AI-powered ultrasound system Versana Premier R3
The launch of Wipro GE Healthcare’s Versana Premier R3 ultrasound system marks a significant milestone in India’s healthcare innovation journey
Arecent PwC report has noted that 57 per cent of India’s healthcare providers are utilising AI, a significantly higher number than the global average. This makes India the emerging global leader in adopting AI-driven healthcare solutions. AI is central to addressing India’s healthcare challenges—bridging the access to quality healthcare for India’s 1.4 billion. Now, when we speak about India, home to the world’s largest population and a threatening burden of non-communicable diseases, preventive, predictive and personalised care become the three essential tenets to optimise patient outcomes. Especially, from the lens of diagnostics, the first leg of any treatment.
The launch of Wipro GE Healthcare’s Versana Premier R3 ultrasound system marks a significant milestone in India’s healthcare innovation journey. Designed to help enhance clinical efficiency and diagnostic accuracy, this AI-enabled ultrasound system is a testament to India’s growing prominence in Medtech innovation. Manufactured at Wipro GE Healthcare’s
The advanced ultrasound system integrates artificial intelligence and AI-enabled productivity tools to streamline workflows and optimise clinical efficiency
PLI factory in Bengaluru, the Versana Premier R3 supports the government’s Atmanirbhar Bharat initiative, demonstrating a commitment towards “Make in India” for both the domestic and global markets.
“At Wipro GE Healthcare we continue to make advancements in AI, investing in foundation models that can help enhance precision care, ease clinical workflows and enable better patient outcomes. AI is central to building a future where healthcare is personalised, preventive, and affordable. The launch of our Versana Premier R3, is yet another testament to our commitment towards the delivery of ‘Made in India MedTech – for India and the world,” says Chaitanya Sarawate, Managing Director of Wipro GE Healthcare South Asia.
The advanced ultrasound system integrates artificial
intelligence and AI-enabled productivity tools to streamline workflows and optimise clinical efficiency. Designed to assist clinicians in delivering more personalised, preventive, and accessible care, the system enhances dynamic tissue imaging, aids in volume calculations, and automates key processes. Additionally, its self-learning onboarding tool bridges the skill gap by enabling clinicians to refine their expertise and seamlessly adapt to evolving workflows.
The Versana Premier R3 offers diagnostic capabilities featuring Vision Boost technology and 8-million-channel digital processing for enhancing image clarity. Compatibility with 23 different probes provides versatile organ scanning capabilities, ensuring precise diagnoses across a range of medical conditions.
Anup Kumar, Business Head of Ultrasound, Wipro GE
Healthcare, emphasises its impact, “We are very proud to launch the Versana Premier R3, our state-of-the-art our ‘Made in India’ ultrasound system. With the growing NCD burden in the country, there is a pressing need for advanced patient centric technologies that can provide faster, personalised, and more accurate diagnosis. Powered by AI, Versana Premier R3 delivers enhanced image clarity, and versatile organ scanning, enhancing diagnostic precision, and empowering clinicians to make timely and well-informed decisions.”
With its ‘Made in India’ approach and integration of cutting-edge AI capabilities, the Versana Premier R3 underscores a transformative shift in India’s healthcare landscape. It exemplifies Wipro GE Healthcare’s commitment to leveraging AI technologies to enhance
diagnostic precision and support clinicians in delivering highquality care, driving forward innovations that support improved healthcare outcomes across India.
By integrating AI and machine learning, the Versana Premier R3 reduces administrative burdens, allowing clinicians to focus on delivering personalised care. Its domestic production underlines a broader vision of self-reliance, aligning with India’s aspirations to become a global leader in Medtech innovation.
Through initiatives like these, Wipro GE Healthcare is not just manufacturing medical devices but redefining healthcare delivery on a global scale. As India continues to embrace AI in healthcare, innovations like Versana Premier R3 not only address current challenges but also pave the way for a future where healthcare is accessible, affordable, and equitable for all.
With AI-enabled deep learning algorithms and precision-led diagnosis transforming the future of healthcare, Medtech continues to advance and improve diagnosis.
Integration and total lab automation will revolutionise the future of biochemistry
Shobhit Jain, Sr.Manager,Product-Clinical
Chemistry & Urinalysis,Sysmex India,explains why the future of biochemistry lies in automation and Total Lab Automation (TLA)
India's IVD sector is expanding phenomenally, with a strong trajectory to become a major global manufacturing hub for medical devices. The success of the 'Make in India' program has attracted substantial multinational investment, driving manufacturing initiatives. India holds a significant position as the fourth largest Asian IVD market, following China, Japan, and South Korea. Biochemistry remains the leading segment within the Indian IVD market, driving significant growth. With an estimated value of Rs 33 billion Rs in 2024, which is 8 per cent over 2023. Reagents constitute 80.6 per cent and instruments 19.4 per cent, the market's expansion is fueled by the rising prevalence of chronic diseases, the increasing adoption of POC diagnostics, and a growing awareness of per-
sonalised and companion diagnostics
The journey of biochemistry started with very basic measurement systems like colorimeter, flame photometer which was taken over by semi-automatic analyzer and batch analyzers in the next decade. Furthermore, with technological advancement (automatic onboard hemolysis for HbA1c, permanent cuvettes, onboard laun-
ture of biochemistry lies in automation and Total Lab Automation (TLA).
Total Laboratory Automation (TLA) is a system that automates repetitive laboratory tasks using robotic devices. It can help improve efficiency, reduce errors, and increase productivity. Some of the benefits of TLA are efficiency, Safety, quality, specimen tracking and data access. TLA empowers labs to:
Total Laboratory Automation (TLA) is a system that automates repetitive laboratory tasks using robotic devices.It can help improve efficiency,reduce errors,and increase productivity
tegration (modular platform), tools for preanalytical, analytical and post analytical, the fu-
◆ Meet changing needs with agility
◆ Streamline operational efficiency
◆ Advance workflow capabilities
◆ Improve productivity at justified cost.
Other socio-economic factors like growing population, increase in health awareness in tier II and tier III cities, increase in medical tourism resulting in increase in sample load hence there is a growing need of automation which enables fast, cost-efficient, and high-quality testing. In addition to that lab are also expanding their business by expanding menu, opening new branches, and joining hands with existing market leaders, creating good demand for automation. To conclude, small size to high-end laboratories, private to public sector hospitals there is a high demand of automation and will be exponentially growing in future.
PolyMedicure receives MDR certification for 54 products
MDR certificate is a certification that a medical device complies with the European Union's Medical Device Regulation
Poly Medicure Limited, a global leader in medical devices, has received Medical Device Regulation (MDR) certification for 54 of its products, catering to a diverse range of medical specialties, such as Infusion Therapy, Vascular Access, Renal Care, Urology, Surgery & Wound Care, Transfusion Systems, Anaesthesia & Respiratory Care, Gastroenterology, and Diagnostics. The MDR certification reaffirms that these products meet the highest safety, quality, and regulatory standards set by the European Union. This achievement marks a significant milestone for Poly-
This achievement marks a significant milestone for Polymed,reinforcing its commitment to providing innovative and safe medical solutions to healthcare professionals worldwide
med, reinforcing its commitment to providing innovative and safe medical solutions to healthcare professionals worldwide. Commenting on this achievement, Rishi Baid, Joint Managing Director, Poly Medicure said, "Polymed has been the largest exporter of consumable medical devices for over a
decade now. The MDR certification demonstrates that our products not only meet but exceed the most stringent safety and quality standards. We are steadfast in our commitment to these principles, which are at the core of our growth and success. With Europe already contributing half of our export revenue, this certi-
fication will further strengthen our presence and reputation in the European market. It is a testament to our focus on quality, innovation, and customer satisfaction."
An MDR certificate is a certification that a medical device complies with the European Union's Medical Device
Regulation. The European Union’s MDR is a legal framework governing the production, distribution, and marketing of medical devices in the EU. It ensures medical devices meet high safety, quality, and performance standards while enhancing transparency and patient safety. The MDR is a regulation that governs the safety and performance of medical devices in the European Economic Area. The MDR certification reinforces Polymed’s position as a trusted global leader in the medical device industry, with an unwavering focus on quality, safety, and continuous innovation.
REGD.WITH RNI NO.MAHENG/2007/22045,POSTAL REGD.NO.MCS/162/2025 – 27,PUBLISHED ON 8TH EVERY MONTH, POSTED ON 14TH,15TH,16TH EVERY MONTH,POSTED AT MUMBAI PATRIKA CHANNEL SORTING OFFICE,MUMBAI – 400001
